Q&A: Pharmacists Bridge the Gap in Safe Medication Disposal | PQA 2025
Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.
How Community Pharmacies Can Proactively Identify Drug Shortages
David Swenson, RPh, discussed drug shortage technology that his company is helping bring to community pharmacies across the country.
Study Finds Link Between Prenatal Cardiometabolic Factors and Hypertension for Children
By protecting pregnant patients from cardiometabolic risk factors, healthier blood pressure can be promoted for children.
Q&A: How Pressure in the Marketplace Could Enforce PBM Reform
PBM expert Antonio Ciaccia, president of 3 Axis Advisors and CEO of 46brooklyn Research, discussed recent events in the pharmacy benefits industry and how it is moving toward PBM reform.
Q&A: How PBM Practices Were Uncovered in the Ohio Medicaid Program
Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discussed his role in uncovering PBM practices and pharmacy consulting.
Prenatal Use of Triptans Does Not Increase Risk of Autism, ADHD in Children
Triptans are often a first-line treatment for migraine and can be used to treat menstrual migraine and cluster headaches.
Impact of IRA Insulin Cap on Rates of Persistence to Basal Insulin | PQA 2025
A conversation with Razanne Oueini, PharmD, MSc, CPHQ, senior manager of Performance Measurement at PQA, at PQA 2025.
Dupilumab Can Safely Treat Atopic Dermatitis During Pregnancy
Researchers explored the current evidence regarding women’s reactions to biological therapies for treating atopic dermatitis during pregnancy.
Majority of Americans Understand Risks of Increased Acetaminophen Usage
Acetaminophen exposure can increase the risk of perforation, ulceration, bleeding, heart failure, hypertension, and chronic kidney disease.
Q&A: The New Technology Helping Pharmacies Facilitate Drug Shortages
David Swenson, RPh, Founder and CEO of ShortStop Rx, joined Drug Topics to discuss the CCT Rx Shortage Solutions technology and how it’s helping combat drug shortages in the US.
FDA Grants Expanded Interchangeability Designation to Yuflyma
Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.
FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body
The supplemental new drug application for roflumilast (Zoryve) is approved for adult and pediatric patients 12 years and older.
FDA Approves Mepolizumab for Treatment of COPD Exacerbations
Approval comes from positive results in the MATINEE and METREX phase III trials, with data showing a significant reduction in annual rates of COPD exacerbations among patients.
Automated Insulin Delivery System to Be Integrated with Glucose-Ketone Sensor
Insulin delivery technology company Sequel Med Tech announced its future partnership with Abbott’s glucose-ketone sensor, which is currently under development.
Access, Innovation, and the Changing Face of Pharmacy | PQA 2025
A conversation with Micah Cost, PharmD, MS, CAE, CEO of PQA, at PQA 2025.
The Common Trends in Hepatitis Vaccine Uptake, Hesitancy
During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.
Evernorth Benefit Option Will Cap Wegovy, Zepbound Monthly Cost at $200
The new program aims to reduce costs for patients, with savings estimated at as much as $3600 per year.
Atopic Dermatitis Associated With Higher Dementia Risk
Through a comprehensive review and meta-analysis, researchers identified the correlation between atopic dermatitis and dementia.
Community Pharmacies Help Enhance Patient Access, Education | PQA 2025
A conversation with Kaitlin Bates, PharmD, ARHOME Quality Manager at Arkansas Blue Cross and Blue Shield, at PQA 2025.
FDA Will Make Importing Prescription Drugs From Canada Easier for States
Importing prescription drugs from Canada has been met with criticism, such as weakening the pharmaceutical supply chain and posing increased risks to patient safety.
CTx-1301 Demonstrates Improvements in ADHD Across 3 Dosages
Patients included in the study were aged 6 to 17 years with attention deficit/hyperactivity disorder (ADHD).
FDA Grants Interchangeability Designation to Ustekinumab-Aauz for Stelara
Pharmacists can substitute ustekinumab with the biosimilar at the pharmacy level, depending on their state laws.
Adult MTM Models for Children Could Improve Medication Costs, Effectiveness
Researchers investigate annual medication costs for children and determine which of them would qualify for medication therapy management based on CMS thresholds.
Deprescribing Leads to Reduction in Polypharmacy, Inappropriate Medication Use
Researchers aim to understand how deprescribing interventions impacted changes in inappropriate medication use or total prescription drugs among older, community-dwelling adults.
The Future of Patient Care Services in Community Pharmacy | PQA 2025
A conversation with Michael Hegener, PharmD, BCACP, associate professor of Pharmacy at the University of Cincinnati, at PQA 2025.
V116 Pneumococcal Vaccine Shows Noninferiority to PPSV23
V116 is noninferior to 23-valent pneumococcal polysaccharide vaccine (PPSV23) for all 12 common serotypes and superior to 9 unique serotypes.
Pharmacists Crucial in Addressing Hepatitis Vaccination Gaps
President of the National Foundation for Infectious Diseases, Jeff Goad, PharmD, MPH, discusses how pharmacists can help improve hepatitis A and B vaccine rates across the country.
More Americans Now Believe MMR Vaccine Causes Autism vs 2021
Approximately 67% of adults in the US know that vaccines do not cause autism in children, declining significantly from 74% in 2021.
The Potential Impacts of Targeted Drug Advertising on Social Media
In part 2 of our video series with drug market experts Luke Turnock, PhD, and Jenny Markell, we explored social media advertisements for prescription drugs and how they may impact patients.
Pharmacies Can Drive Medication Safety Through Drug Disposal Programs | PQA 2025
A conversation with Mitchell Barnett, PharmD, MS, professor of pharmaceutical sciences at Texas A&M University, at PQA 2025.
